NCT00434954 Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00433290 Duloxetine vs. Placebo in the Treatment of Osteoarthritis Knee Pain Status COMPLETED Phase PHASE3
NCT00429858 Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer Status TERMINATED Phase PHASE2
NCT00428714 Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and Chemotherapy Status COMPLETED Phase PHASE2
NCT00428610 A Study of Chemotherapy Treatment for Patients With Ovarian Cancer Status COMPLETED Phase PHASE2
NCT00422734 Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and Maintaining an Erection and Sexual Quality of Life Status COMPLETED Phase PHASE3
NCT00422578 Effect of Tadalafil on the Quality of Life and Sexual Life in Erectile Dysfunction Status COMPLETED Phase PHASE4
NCT00422162 A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression Status COMPLETED Phase PHASE4
NCT00421083 Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury Status COMPLETED Phase PHASE3
NCT00420381 Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal Cancer Status COMPLETED Phase PHASE2
NCT00420030 Abciximab in Patients Undergoing Percutaneous Coronary Intervention for Cardiogenic Shock Status COMPLETED Phase PHASE4
NCT00418093 Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma Status TERMINATED Phase PHASE2
NCT00417794 Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD Status COMPLETED Phase PHASE1
NCT00415636 Safety and Tolerability of IC83/LY2603618 Administered After Pemetrexed 500 mg/m2 Every 21 Days in Patients With Cancer Status COMPLETED Phase PHASE1
NCT00415363 Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy Status COMPLETED Phase PHASE2